Clinical exome sequencing in neurogenetic and neuropsychiatric disorders
暂无分享,去创建一个
[1] W. Chung,et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.
[2] S. Bale,et al. Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort , 2014, Genetics in Medicine.
[3] Xiang Li,et al. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.
[4] Yuan Xue,et al. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing , 2014, Genetics in Medicine.
[5] Lars T Westlye,et al. Polygenic risk for schizophrenia associated with working memory-related prefrontal brain activation in patients with schizophrenia and healthy controls. , 2015, Schizophrenia bulletin.
[6] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[7] Joshua L. Deignan,et al. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. , 2015, American journal of human genetics.
[8] Y Wang,et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci , 2014, Molecular Psychiatry.
[9] P. Sullivan,et al. No evidence for rare recessive and compound heterozygous disruptive variants in schizophrenia , 2014, European Journal of Human Genetics.
[10] A. StAteMent. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing , 2014, Genetics in Medicine.
[11] T. Wassink,et al. A genome‐wide CNV analysis of schizophrenia reveals a potential role for a multiple‐hit model , 2014, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[12] N. Matsumoto,et al. Genetics: Clinical exome sequencing in neurology practice , 2014, Nature Reviews Neurology.
[13] D. Rujescu,et al. Exome Sequencing in 53 Sporadic Cases of Schizophrenia Identifies 18 Putative Candidate Genes , 2014, PloS one.
[14] Magalie S Leduc,et al. Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.
[15] Eric Vilain,et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.
[16] D. G. Clark,et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. , 2014, JAMA neurology.
[17] Siddharth Srivastava,et al. Clinical whole exome sequencing in child neurology practice , 2014, Annals of neurology.
[18] Soma Das,et al. Clinical exome sequencing: the new standard in genetic diagnosis. , 2014, JAMA neurology.
[19] Joshua L. Deignan,et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. , 2014, JAMA neurology.
[20] Sebastien Ourselin,et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. , 2014, JAMA neurology.
[21] M. Nalls,et al. Genome-wide analysis of the heritability of amyotrophic lateral sclerosis. , 2014, JAMA neurology.
[22] James T Lu,et al. Genotype-phenotype correlation--promiscuity in the era of next-generation sequencing. , 2014, The New England journal of medicine.
[23] L. Vissers,et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. , 2014, American journal of human genetics.
[24] Julia Wynn,et al. The usefulness of whole-exome sequencing in routine clinical practice , 2014, Genetics in Medicine.
[25] A. Singleton,et al. Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations , 2014, Human molecular genetics.
[26] G. Comi,et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. , 2014, Human molecular genetics.
[27] J. Shendure,et al. A de novo convergence of autism genetics and molecular neuroscience , 2014, Trends in Neurosciences.
[28] Allyn McConkie-Rosell,et al. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders , 2013, Genetics in Medicine.
[29] J. Veltman,et al. Clinical exome sequencing in daily practice: 1,000 patients and beyond , 2014, Genome Medicine.
[30] Eric Vilain,et al. Assessing the necessity of confirmatory testing for exome sequencing results in a clinical molecular diagnostic laboratory , 2014, Genetics in Medicine.
[31] Mustafa Tekin,et al. The promise of whole-exome sequencing in medical genetics , 2013, Journal of Human Genetics.
[32] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[33] Qingguo Wang,et al. Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives , 2013, BMC Bioinformatics.
[34] Utilization of genetic testing prior to subspecialist referral for cerebellar ataxia. , 2013, Genetic testing and molecular biomarkers.
[35] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[36] Tommaso Mazza,et al. Congruency in the prediction of pathogenic missense mutations: state-of-the-art web-based tools , 2013, Briefings Bioinform..
[37] Sudhir Kumar,et al. Performance of computational tools in evaluating the functional impact of laboratory-induced amino acid mutations , 2012, Bioinform..
[38] J. Shendure,et al. Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.
[39] Hugo Y. K. Lam,et al. Performance comparison of exome DNA sequencing technologies , 2011, Nature Biotechnology.
[40] Brent L Fogel. Interpretation of genetic testing: variants of unknown significance. , 2011, Continuum.
[41] M. Vihinen,et al. Performance of mutation pathogenicity prediction methods on missense variants , 2011, Human mutation.
[42] Kenny Q. Ye,et al. Mapping copy number variation by population scale genome sequencing , 2010, Nature.
[43] A. Al-Chalabi,et al. An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[44] S. Ferdinandusse,et al. Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene , 2010, Journal of Medical Genetics.
[45] Leslie G Biesecker,et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.
[46] S. Nelson,et al. Improving the efficiency of genomic loci capture using oligonucleotide arrays for high throughput resequencing , 2009, BMC Genomics.
[47] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[48] David T. Okou,et al. Microarray-based genomic selection for high-throughput resequencing , 2007, Nature Methods.
[49] Philip M. Kim,et al. Paired-End Mapping Reveals Extensive Structural Variation in the Human Genome , 2007, Science.
[50] G. Weinstock,et al. Direct selection of human genomic loci by microarray hybridization , 2007, Nature Methods.
[51] Hanlee P. Ji,et al. Multigene amplification and massively parallel sequencing for cancer mutation discovery , 2007, Proceedings of the National Academy of Sciences.
[52] Hanlee P. Ji,et al. Multiplex amplification of all coding sequences within 10 cancer genes by Gene-Collector , 2007, Nucleic acids research.
[53] James R. Knight,et al. Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.
[54] J. Shendure,et al. Materials and Methods Som Text Figs. S1 and S2 Tables S1 to S4 References Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome , 2022 .
[55] Fredrik Dahl,et al. Multiplex amplification enabled by selective circularization of large sets of genomic DNA fragments , 2005, Nucleic acids research.
[56] F. Collins,et al. The Human Genome Project: Lessons from Large-Scale Biology , 2003, Science.
[57] International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome , 2001, Nature.
[58] Arnold Munnich,et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.
[59] D. Church,et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.
[60] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[61] T. Bird,et al. Clinical neurogenetics , 1977, Neurology.